This report from a French group looked at relapse data for more than 1000 people in three countries, and found that quality of life measures correlate with relapse (53% in the 24 month period they followed) better than other factors – like age, functioning or compliance.
The authors conclude that:
“QoL, as assessed by the SF36, is an independent predictor of relapse at a 24-month follow-up in schizophrenia. This finding may have implications for future use of the QoL in psychiatry. Moreover, our findings may support the development and monitoring of complementary therapeutic approaches, such as ‘recovery-oriented’ combined with traditional mental health cares to prevent relapse.”
This article is freely available from Biomed Central – BMC Psychiatry at http://www.biomedcentral.com/1471-244X/13/15/abstract